EDRONAX

This brand name is authorized in Austria, Australia, Estonia, Croatia, Ireland, Israel, New Zealand, Poland, Turkey, United Kingdom, South Africa

Active ingredients

The drug EDRONAX contains one active pharmaceutical ingredient (API):

1 Reboxetine
UNII L94J81YNNY - REBOXETINE MESYLATE

Reboxetine is a highly selective and potent inhibitor of noradrenaline reuptake. Noradrenaline reuptake inhibition and the consequent increase of noradrenaline availability in the synaptic cleft and modification of noradrenergic transmission, reportedly is among the most relevant mechanisms of action of known antidepressant drugs.

Read about Reboxetine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
EDRONAX Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N06AX18 Reboxetine N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX18

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 8583R
Country: EE Ravimiamet Identifier(s): 1070930, 1640786, 1888500
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 142158, 161701, 22018, 373799
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-843519291
Country: IE Health Products Regulatory Authority Identifier(s): 22861
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 4070
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 8169
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100098326
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8681308011008
Country: ZA Health Products Regulatory Authority Identifier(s): 33/1.2/0246

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.